Bit Origin
BTOG
Strategy
MSTR
Bit Digital
BTBT
Bitfarms
BITF
Canaan
CAN
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.010
- +0.010+0.33%
Close Mar 4 16:00 ET
- 3.010
- 0.0000.00%
Post 20:01 ET
266.69MMarket Cap-0.68P/E (TTM)
3.170High2.600Low1.71MVolume2.800Open3.000Pre Close5.14MTurnover2.87%Turnover RatioLossP/E (Static)88.60MShares7.27052wk High1.62P/B178.94MFloat Cap1.57552wk Low--Dividend TTM59.45MShs Float41.930Historical High--Div YieldTTM19.00%Amplitude1.575Historical Low3.010Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Amylyx Pharmaceuticals Stock Forum
Can Amylyx Recover? Q4 Results Show $301.7M Loss But Pipeline Progress and Extended Cash Runway
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals (NASDAQ: AMLX) announced that the FDA has lifted the clinical hold on its Phase 1 clinical trial of AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS treatment. The company will proceed with opening U.S. sites for screening, enrollment, and dosing.
The Phase 1 LUMINA cl...
No comment yet